EYEN
Price:
$7.56
Market Cap:
$17.22M
Eyenovia, Inc., a New York-based company established in 2014 (originally incorporated as PGP Holdings V, Inc.), functions as a clinical-stage pharmaceutical firm specializing in ophthalmology. The company utilizes its exclusive microdose array print platform technology and the Optejet branded targeted ocular delivery system to formulate innovative eye treatments. Its primary focus for research and development lies in addressing progressive myopia (nearsightedness), age-related near vision impairment (presbyopia), and pharmacologically induced pupil dilation for eye examinations. Eyenovia's developmental pipeline includes several advanced candidates, all currently undergoing Phase III clinica...[Read more]
Industry
Biotechnology
IPO Date
2018-01-25
Stock Exchange
NASDAQ
Ticker
EYEN
According to Eyenovia, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.18. This represents a change of -118.77% compared to the average of 0.94 of the last 4 quarters.
The mean historical PE Ratio of Eyenovia, Inc. over the last ten years is -0.18. The current -0.18 PE Ratio has changed 9.71% with respect to the historical average. Over the past ten years (40 quarters), EYEN's PE Ratio was at its highest in in the March 2026 quarter at 2.88. The PE Ratio was at its lowest in in the March 2025 quarter at -0.48.
Average
-0.18
Median
-0.14
Minimum
-0.38
Maximum
-0.11
Discovering the peaks and valleys of Eyenovia, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 187.09%
Maximum Annual PE Ratio = -0.11
Minimum Annual Increase = -40.96%
Minimum Annual PE Ratio = -0.38
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.38 | 187.09% |
| 2024 | -0.13 | -11.14% |
| 2023 | -0.15 | 24.93% |
| 2022 | -0.12 | -40.96% |
| 2021 | -0.20 | 91.63% |
The current PE Ratio of Eyenovia, Inc. (EYEN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.22
5-year avg
-0.20
10-year avg
-0.18
Eyenovia, Inc.’s PE Ratio is greater than Cerecor Inc. (-0.53), greater than Lumos Pharma, Inc. (-1.04), greater than Satsuma Pharmaceuticals, Inc. (-0.51), greater than Pluristem Therapeutics Inc. (-0.27), less than Lunai Bioworks Inc. (-0.06), less than LianBio (2.47), less than Magenta Therapeutics, Inc. (-0.02), greater than Marinus Pharmaceuticals, Inc. (-0.21), greater than GreenLight Biosciences Holdings (-0.24), greater than Spyre Therapeutics, Inc. (-40.52),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.53 | $38.63M | |
| -1.04 | $37.54M | |
| -0.51 | $36.47M | |
| -0.27 | $40.85M | |
| -0.06 | $32.92M | |
| 2.47 | $12.11M | |
| -0.02 | $42.44M | |
| -0.21 | $30.37M | |
| -0.24 | $45.43M | |
| -40.52 | $5.34B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eyenovia, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eyenovia, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Eyenovia, Inc.'s PE Ratio?
How is the PE Ratio calculated for Eyenovia, Inc. (EYEN)?
What is the highest PE Ratio for Eyenovia, Inc. (EYEN)?
What is the 3-year average PE Ratio for Eyenovia, Inc. (EYEN)?
What is the 5-year average PE Ratio for Eyenovia, Inc. (EYEN)?
How does the current PE Ratio for Eyenovia, Inc. (EYEN) compare to its historical average?